Kevin Perkins

Kevin Perkins has a diverse work history in the medical field. Kevin is currently the Director Precision Medicine Executive Field Leader at Blueprint Medicines, where they focus on integrating precision medicine diagnostics into standard care decision making. Prior to this role, they served as an Associate Director Precision Medicine at the same company, where they were involved in launching several oncology and rare disease therapies. Before joining Blueprint Medicines, Kevin worked as the Sr. Manager, Regional Oncology Sales at Ambry Genetics and as an Oncology DX Account Executive at Foundation Medicine. Kevin also has experience at Counsyl, Oxford Immunotec, Cancer Genetics, LabCorp, Genzyme Genetics, Matritech Inc., and Polymedco, where they held various sales and management positions within the medical industry.

Kevin Perkins attended The University of Texas at San Antonio from 1989 to 1993, where they obtained a Bachelor of Arts (B.A.) degree. Additionally, they completed the Miller Heiman Strategic Selling certification and the Situational Leadership II certification from the American Management Association in 2015. Kevin also attended Tom Clark HS, although no dates or qualifications are provided for this education.